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Translocon-associated protein (TRAP) complex is intimately associated with 
the ER translocon for the insertion or translocation of newly synthesised 
proteins in eukaryotic cells. The TRAP complex is comprised of three single-
spanning and one multiple-spanning subunits. We have investigated the 
membrane insertion and topology of the multiple-spanning TRAP-γ subunit 
by glycosylation mapping and green fluorescent protein fusions both in vitro 
and in cell cultures. Results demonstrate that TRAP-γ has four 
transmembrane (TM) segments, an Nt/Ct cytosolic orientation and that the 
less hydrophobic TM segment inserts efficiently into the membrane only in 
the cellular context of full-length protein. 
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ER, endoplasmic reticulum; GFP, green fluorescent protein; HR, hydrophobic 
region; Lep, leader peptidase; SDS-PAGE, sodium dodecylsulfate 
polyacrylamide gel electrophoresis; SRP, signal recognition particle; TM, 
transmembrane; TRAP, translocon-associated protein. 
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1. Introduction 
In eukaryotic cells insertion of most integral membrane proteins into the 
endoplasmic reticulum (ER) membrane occurs primarily in a co-translational 
manner. In this process, targeting of the ribosome–mRNA–nascent chain 
complex to the ER depends on the signal recognition particle (SRP) and its 
interaction with the membrane-bound SRP receptor. The ribosome and the 
nascent chain are then transferred to the translocon, a multi-protein complex 
that facilitates insertion of integral membrane proteins into the lipid bilayer 
and translocation of secreted proteins across the lipid bilayer [1]. Translocons 
are not passive pores in the bilayer, but instead are dynamic complexes that 
cycle between ribosome-bound and ribosome-free states, and convert 
between translocation and membrane integration modes of action, while 
maintaining the membrane permeability barrier [2, 3]. The core components 
of the mammalian translocon are the Sec61 α, β and γ subunits [4] and the 
translocating chain-associating membrane protein [5, 6]. However, several 
other proteins including the signal peptidase, the oligosaccharyltransferase 
(OST), PAT-10, RAMP4, BAP31 or the translocon-associated protein (TRAP) 
complex, interact at some point with the core translocon modulating its 
activity [1]. 
The TRAP complex is comprised of four membrane protein subunits. 
The α, β, and δ-subunits are single-spanning proteins with suggested large N-
terminal (Nt) luminal and small C-terminal (Ct) cytosolic domains, while γ-
subunit was proposed to cross the membrane four times with a putative 
Nt/Ct luminal orientation [7]. This complex remains stably associated with 
detergent-solubilised ribosome-translocon complexes [8], being an integral 
part of the translocon. Despite notorious efforts, the role of TRAP complex 
during membrane insertion or translocation is not fully understood. It has 
been proposed that TRAP complex acts, in a substrate-specific manner, 
facilitating the initiation of protein translocation [9]. It has also been 
suggested a role of TRAP complex in membrane topology regulation by 
moderating the ‘positive-inside’ rule [10] of membrane proteins with weak 
topogenic determinants [11]. The TRAP complex is also involved in ER 
associated degradation, where its function might be to recruit misfolded 
proteins to the translocon [12]. Most of these studies have been carried out 
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using in vitro reconstituted systems, mainly with microsomal membranes. Its 
role in membrane protein biogenesis has been emphasised in vivo, where it 
has been shown that TRAP-α subunit mutant alters mammalian heart 
development [13], a mutation in TRAP-δ has been related to human 
congenital disorders of glycosylation [14], and TRAP-γ subunit plays an 
important role in the process of pronephros differentiation during Xenopus 
development [15], and appears to be required for vascular network formation 
in murine placental development [16]. Despite the general importance of the 
TRAP complex in secreted and membrane protein biogenesis, and the 
particular involvement of TRAP-γ subunit in development, its membrane 
topology has not been thoroughly investigated. 
In this study, we investigated TRAP-γ subunit biogenesis both in vitro 
and in vivo using N-glycosylation- and fluorescence-based topological 
reporters. Our results reveal that TRAP-γ is a tetra-spanning membrane 
protein with an Nt/Ct cytosolic orientation. Furthermore, we identified the 
precise position of all four TM segments and established the topology of the 
protein at multiple stages of its biogenesis by translating a series of TRAP-γ 
truncations containing appropriate reporter tags. The results suggest that the 
membrane integration of some poorly hydrophobic transmembrane (TM) 
segments is only effective within the global context of the full-length TRAP-γ 
protein in a cellular environment. 
 
2. Materials and methods 
2.1. Enzymes and chemicals.  
All enzymes, as well as plasmid pGEM1, RiboMAX SP6 RNA 
polymerase system and rabbit reticulocyte lysate were from Promega 
(Madison, WI). ER rough microsomes from dog pancreas were from tRNA 
Probes (College Station, TX, USA). [35S]Met and [14C]-methylated markers were 
from Perkin Elmer. Restriction enzymes and Endoglycosidase H were from 
Roche Molecular Biochemicals. Proteinase K was from Sigma-Aldrich (St 
Louis, MO). The DNA plasmid, RNA clean up and PCR purification kits were 
from Thermo Fisher Scientific (Ulm, Germany). All oligonucleotides were 
purchased from IDT (USA). 
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2.2. Computer-assisted Analysis of TRAP-γ sequence.  
Prediction of TM helices was done using a pletora of the most common 
methods available on the Internet: ΔG Prediction Server [17, 18] 
(http://www.cbr.su.se/DGpred/), HMMTOP [19] 
(http://www.enzim.hu/hmmtop/), MEMSAT [20] 
(http://www.bioinf.cs.ucl.ac.uk/psipred/psiform.html), PHD [21] 
(http://www.cubic.bioc.columbia.edu/pp/) , SOSUI [22] 
(http://bp.nuap.nagoya-u.ac.jp/sosui/), SPLIT [23] 
(http://split.pmfst.hr/split/4/), TMHMM [24] 
(http://www.cbs.dtu.dk/services/TMHMM), TMPred 
(http://www.ch.embnet.org/software/TMPRED_form.html), OCTOPUS [25] 
(http://octopus.cbr.su.se/), TOPCONS [26] (http://topcons.net/) and 
TopPRED [27] (http://www.sbc.su.se/~erikw/toppred2/). 
2.3. DNA Manipulation.  
The full-length TRAP-γ sequence was cloned from a mouse brain 
cDNA library into pGEM-T plasmid as previously described [6]. Insertion of 
T111 and mutation G5N were performed using the QuikChange PCR 
mutagenesis kit from Stratagene (La Jolla, CA) following the manufacturer's 
protocol. For construction of plasmids encoding glycosylatable GFP (gGFP) 
fusion proteins TRAP-γ sequence was subcloned into the yeast HA-gGFP 
vector [28], which contained the GFP sequence with an additional 
glycosylation site, between the PstI/BamHI restriction sites, to obtain a 
construct containing the TRAP-γ subunit with gGFP fused in frame at the C-
terminus. All DNA manipulations were confirmed by sequencing of plasmid 
DNAs at Macrogen Company (Seoul, South Korea). 
2.4. In vitro transcription and translation.  
Constructs cloned in pGEM-T were transcribed and translated in the 
presence of [35S]Met/Cys as previously reported [29, 30]. In all cases, after 
translation membranes were collected by ultracentrifugation and analysed by 
sodium-dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 
Finally, autoradiographies of the gels were visualized on a Fuji FLA3000 
phosphorimager and Image Reader 8.1j software. 
2.5. In vitro Endoglycosidase H and Proteinase K treatment.  
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Endoglycosidase H (EndoH, Roche) treatment was done as previously 
decribed [31]. For the proteinase K protection assay, the translation mixture 
was supplemented with 1 μL of 50 mM CaCl2 and 1 μL of proteinase K (2 
mg/mL), then digested for 40 min on ice. The reaction was stopped by adding 
2 mM PMSF before SDS-PAGE analysis [32]. 
2.6. Protein preparation from yeast and Western blot analysis.  
Yeast cells transformed with plasmids mentioned above, were grown 
in SD–Trp (synthetic dextrose) medium [0.67% yeast nitrogen base, synthetic 
mixture-TRP (drop-out) and 2% glucose]. Approximately 108 yeast cells were 
resuspended in 50 mM Tris/HCl (pH 7.5) supplemented with a mixture of 
protease inhibitors and broken with vigorous shaking in the presence of glass 
beads. The lysate was removed from the intact cells and the debris by 
centrifuged 2000g for 5 min at 4ºC. The supernatant was denatured by adding 
1 volume of denaturation buffer [1mM Tris/HCl (pH 7.5), 40 m M DTT and 
0.5% SDS] and incubated for 5 min at 95ºC. Samples were diluted 2-fold (final 
concentration 0.25% SDS) and adjusted to a final concentration of 0.2 mM 
ammonium acetate (pH 5.5). The sample was divided into two aliquots: one 
was treated with 50 mU of EndoH; and the other incubated with buffer at 
37ºC for 2 h. Proteins were resolved by SDS-PAGE (10% gel), immunoblotted 
and detected using the corresponding antibody (anti-GFP monoclonal 
antibody, Roche) and the SuperSignal ® Western blotting detection kit 
(Thermo Scientific) according to the manufacturer ́s instructions. 
2.7. Fluorescence microscopy.  
GFP tagged constructs were analysed in living cells grown overnight 
on selective medium SD-Trp. Samples were visualized in an Axioskop 2 
Fluorescence Microscope (Zeiss Inc.), and pictures were taken using an 
AxioCam MRm (Zeiss Inc.). 
2.8. TRAP-γ expression in mammalian cells.  
TRAP-γ sequence was fused to a FLAG-tag sequence and inserted in a 
pSELECT-puromicin plasmid. Once sequenced verified the plasmid was 
transfected into HEK 293-T cell using Lipofectamine 2000 (Life Technologies) 
according to the manufacturer's instructions. Approximately 24 hours post-
transfection cells were collected and washed with PBS. After a short 
centrifugation (1000 rpm for 5 minutes on a table-top centrifuge) cells were 
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lysed by adding 300 %L of Lysis Buffer (30 mM Tris-HCl, 150 mM NaCl, 0.5% 
NP-40, Protease inhibitor (complete Protease Inhibitor Cocktail, Roche) and 
phosphatase inhibitor (PhosSTOP, Roche). After 20 min incubation on ice, 
total protein was quantified (Bradford) and equal amounts of protein 
submitted to Endo H treatment or mock treated, followed by SDS-PAGE 
analysis and transferred into an PVDF transfer membrane (ThermoFisher 
Scientific). Protein glycosylation status was analysed by Western Blott using 
an anti-flag antibody. 
 
3. Results  
3.1. Identification and location of TRAP-γ subunit transmembrane segments.  
Early work predicted TRAP-γ subunit to span the ER membrane four 
times with an Nt/Ct lumenal orientation [7]. First, as a preliminary test, we 
analysed TRAP-γ sequence for TM segments using a plethora of membrane 
protein prediction algorithms. As shown in Table 1, the predicted outcome 
displayed variability according to the methods used, likely due to the limited 
hydrophobicity of the most C-terminal predicted membrane-spanning 
segment, which contains several hydrophilic residues, particularly amino 
acids with hydroxyl groups (see Fig. 1A). Next, the membrane insertion 
capacity for the predicted membrane-spanning segments was analysed using 
an in vitro assay based on the E. coli leader peptidase (Lep). Lep consists of 
two TM segments (H1 and H2) connected by a cytoplasmic loop (P1) and a 
large C-terminal domain (P2), and inserts into ER-derived microsomal 
membranes with an Nt/Ct luminal orientation (Fig. 1B). This assay allows 
accurate analysis and quantification of the membrane insertion capability of 
short sequences. The hydrophobic region (HR) to be tested is inserted into the 
luminal P2 domain flanked by two N-glycosylation acceptor sites (G1 and G2, 
tripeptide Asn-X-Ser/Thr sequences, where X can be any amino acid except 
Pro) [17, 18]. N-linked glycosylation has been extensively used as topological 
reporter for more than two decades [33]. This post-translational modification 
occurs only in the lumen of the ER because the active site of OST, a 
translocon-associated enzyme responsible for oligosaccharide transfer, is 
located there [34]; thus, no N-linked glycosylation occurs in polypeptide 
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sequences spanning the membrane or facing the cytosol. When the tested HR 
region is recognized by the translocon as a TM segment and inserted into the 
membrane, only G1 (not G2) localizes in the ER lumen rendering a single-
glycosylated Lep version (Figure 1B, left). On the other hand, if the tested 
region is fully translocated across the lipid bilayer both G1 and G2 sites locate 
in the ER lumen and are, subsequently, glycosylated by the OST (Fig. 1B, 
right). Glycosylation of an acceptor site increases the molecular mass of the 
protein by ≈2.5 kDa relative to the observed molecular mass in the absence of 
membranes, allowing monitoring the insertion into the membrane of the 
tested HR by SDS-PAGE. 
Translation of Lep chimeric constructs harbouring the TRAP-γ TM 
regions predicted by the ∆G Prediction Server [residues 30-51 (HR1, ∆Gpredapp = 
−0.89 kcal/mol), 55-77 (HR2, ∆Gpredapp = +0.97 kcal/mol), 138-160 (HR3, ∆Gpredapp = 
−1.12 kcal/mol) and 163-182 (HR4, ∆Gpredapp = +1.78 kcal/mol), Figure 1A] 
resulted mainly in single-glycosylated forms (HR1, HR2 and HR3) except for 
HR4 (Figure 1C, lane 11). In this last case, the Lep construct containing HR4 is 
found mostly doubly-glycosylated. These results were confirmed by 
proteinase K (PK) treatment. Digestion with PK degrades membrane protein 
domains located exclusively towards the cytosol, while membrane-embedded 
or lumenally exposed domains are protected. As expected, Lep chimeras 
bearing HR1, HR2 and HR3 regions were sensitive to PK digestion (Figure 1C, 
lanes 3, 6 and 9). However, Lep constructs containing TRAP-γ HR4 sequence 
were partially resistant to the protease treatment due to its luminal P2 
localization (Figure 1C, lane 12, arrowhead, expected size ≈33.5 kDa). It 
should be mentioned that TRAP-γ sequence includes a native potential N-
glycosylation site at position 141, i.e. within HR3 (see Fig. 1A), the membrane-
embedded location of this site precludes its modification (Fig. 1C, lanes 7-9). 
In our in silico analysis, the algorithms predicting membrane protein 
topology agree on an Nt cytoplasmic orientation for TRAP-γ subunit (Table 
1). In this scenario, HR1 and HR3 would adopt an Nt-cytosolic/Ct-luminal 
orientation when inserted into the lipid bilayer. That is, the opposite 
orientation than in the Lep system, where they are forced to adopt an Nt-
luminal/Ct-cytosolic disposition (Fig. 1B). To test the membrane insertion of 
these HRs in its predicted orientation, we used a Lep-derived system (Lep') 
(Fig. 2A) [29, 35]. In this assay, the HR to be tested replaces Lep H2 domain. 
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Then, the second glycosylation site (G2') remains located at P2, while the first 
acceptor site (G1') has been embedded in an extended N-terminal sequence. 
Contrarily to the original Lep system a doubly glycosylated Lep' connotes 
membrane insertion of the tested HR, whilst single glycosylation implies that 
the tested hydrophobic segment has not been recognized as a TM domain by 
the translocon machinery. As shown in Figure 2B, TRAP-γ HR1 and HR3 
inserted efficiently into the microsomal membranes (lanes 2 and 5 
respectively). These results were confirmed by PK treatment. It is worth 
noting that in Lep' constructs P2 protection from proteinase K treatment 
(expected size ≈32.5 kDa) denotes insertion of the tested region (Figure 2B, 
lanes 3 and 6). 
TRAP-γ HR1 and HR2 are connected by a small extra-membranous 
region of 3 residues, similarly HR3 and HR4 are separated by just 2 amino 
acid residues (Fig. 1A). Furthermore, the residues in these two short 
connecting regions display high turn-inducing propensities [36], suggesting 
the presence of two α-helical TM hairpins. It has been observed that a 
neighbouring TM helix can promote the insertion of a flanking poorly 
hydrophobic TM segment [29, 32, 37, 38]. Therefore, the low insertion capacity 
observed for HR4 might increase in the presence of its preceding HR3 
domain. To test this hypothesis, we analysed the insertion of the full-length 
putative α-helical hairpin regions (residues 30-77 or 138-182) in the Lep’ 
system, since Lep’ allows the insertion of both hairpins in the predicted 
orientations (Table 1 and Fig. 2C). As expected, according to the observed 
insertion efficiency for isolated HR1 and HR2 in Lep and Lep’ systems, 
translation of Lep’ constructs harbouring HR1-HR2 hairpin (residues 30-77) 
generated single-glycosylated forms, indicating that both HRs are efficiently 
inserted as an α-helical hairpin into the membrane (Fig. 2D, lane 2). However, 
Lep’ constructs harbouring putative HR3-HR4 hairpin (residues 138-182) 
were double-glycosylated (Fig. 2D, lane 5), denoting failure of insertion for 
one of the two HRs, most likely HR4 according to previous results (Figs. 1C 
and 2B). PK treatment of these translation reaction mixtures produced 
complete digestion of HR1-HR2 containing molecules (Fig. 2D, lane 3), and a 
band corresponding to P1-digested molecules (Fig. 2D, lane 6, expected size 
≈34.6 kDa), which contained HR3-HR4 region plus the single-glycosylated P2 
domain (Fig. 2C, right), supporting the low insertion efficiency observed. 
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3.2. TRAP-γ subunit inserts into ER-derived membranes with an Nt/Ct cytosolic 
orientation 
To experimentally map the membrane topology of TRAP-γ subunit, we 
prepared a series of polypeptide truncates containing an added C-terminal 
glycosylation tag (NST), which has proven to be efficiently modified in the in 
vitro reconstituted translation system [30, 39]. The constructs used are shown 
in Fig. 3A. Wild type TRAP-γ subunit carries a native potential glycosylation 
site at position 23 (see Fig. 1A). It has been previously reported that 
glycosylation occurs when the acceptor Asn is at least ~11-13 residues away 
from the membrane [40-42]. Therefore, since TM1 starts around position 30 
according to all the prediction algorithms (Table 1) and our experimental 
data, in case of a TM disposition Asn23 should not be modified 
independently of the location of TRAP-γ N-terminus. However, in case of 
translocation across the microsomal membrane, both Asn23 and the C-
terminal glycosylation tag should be modified rendering doubly-glycosylated 
forms. As shown in Fig. 3B, translation products containing the N-terminal 54 
residues of TRAP-γ sequence, including the first predicted TM segment 
(TM1) plus an optimized glycosylatable C-terminal tag (truncated 54mer 
polypeptides), were efficiently singly-glycosylated in the presence of 
microsomal membranes (lane 2). The nature of these higher molecular weight 
polypeptide species was analysed by endoglycosidase H (EndoH) treatment, 
a highly specific enzyme that cleaves N-linked oligosaccharides regardless of 
their localization. Treatment with EndoH eliminated higher molecular mass 
band (Fig. 3B, lanes 1), confirming the sugar source of their retarded 
electrophoretic mobility and suggesting 54mer insertion into the microsomal 
membrane with an N-terminal cytoplasmic orientation (see Fig. 3D for a 
scheme). To corroborate these results, 54mer translations in the presence of 
microsomal membranes were performed in parallel either with the above 
described C-terminal acceptor tag (NST, Fig. 3C lanes 1 and 2) or with a non-
glycosylatable tag, in which the acceptor Asn was replaced by a non-acceptor 
Gln (QST, Fig. 3C lanes 3 and 4). The efficient glycosylation observed only 
when using the C-terminal acceptor site (Fig. 3C, lane 2), strongly indicate 
that TM1 in the TRAP-γ context is acting as a non-cleavable signal sequence 
and is properly recognized by the translocon machinery to be inserted into 
the membrane with its N-terminus facing the cytosol. 
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Truncated 132mer polypeptides, which include the N-terminal α-
helical hairpin, were poorly glycosylated (13 ± 5% of glycosylation, Fig. 3B 
lane 4), indicating that the second predicted TM segment (TM2) efficiently 
integrates into the membrane (see Fig. 3D top for an illustrative scheme). The 
insertion of the third predicted TM segment (TM3) was tested by translating a 
161-residue truncation with the same C-terminal glycosylatable tag (161mer). 
The glycosylation of this construct (66 ± 9%, Fig. 3B, lane 6) indicates that TM3 
was inserted with its C-terminus oriented towards the ER lumen (see Fig. 3D, 
top). Finally, the intermediate glycosylation efficiency observed for full-length 
protein (185mer) translations (38 ± 3, Fig. 3B, lane 8), supports the existence of 
an equilibrium between insertion-translocation for this last TM segment, 
suggesting that the presence of preceding TM segments causes a noticeable 
increase in the insertion efficiency of HR4, but not enough for full assembly 
into the microsomal membranes, as illustrated in Fig. 3D (bottom). 
3.3. TRAP-γ membrane topology in cells.  
In order to investigate the overall membrane topology of TRAP-γ 
subunit in cellula we used two different approaches. First, the topology of 
TRAP-γ subunit was analysed in vivo in the yeast S. cerevisiae using a 
glycosylatable green fluorescent protein (gGFP) reporter [28]. When oriented 
towards the ER lumen the glycosylation of the gGFP interferes with the 
protein folding and maturation of the fluorophore, rendering the protein non-
fluorescent. On the contrary, the un-modified gGFP moiety is properly folded 
and remains fluorescent when oriented towards the cytosol. Since our in vitro 
results showed an un-efficient integration for the last TM segment, the gGFP 
topology reporter was C-terminally fused to TRAP-γ sequence at position 
161, after TM3 (161mer-gGFP) and at the C-terminal end of the protein 
(residue 185, 185mer-gGFP) to monitor TRAP-γ subunit topology. Figure 4 
shows the glycosylation status (Fig. 4A) and the fluorescence (Fig. 4B) of both 
protein chimeras. To monitor the molecular weight of the un-glycosylated 
protein, the samples were treated with EndoH. The 161mer-gGFP chimera 
was efficiently mono-glycosylated (Fig. 4A, lane 1) and subsequently no 
fluorescence was observed (Fig. 4B), indicating a lumenal orientation of the 
reporter moiety. Conversely, 181mer-gGFP was not glycosylated (Fig. 4A) 
and thus fluorescent (Fig. 4B), demonstrating the cytosolic localisation of full-
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length TRAP-γ C-terminus and the concomitant insertion into the yeast 
membranes of TM4 (see Fig. 4C for a scheme). It should be mentioned that 
native acceptor asparagine (Asn23) was never modified. 
Second, to analyse the protein topology in mammalian cells, a series of 
TRAP-γ variants were transfected into HEK-293T cells. As expected, wild 
type TRAP-γ subunit is not glycosylated in mammalian cells (Fig. 4D, lanes 1 
and 2), in good agreement with yeast glycosylation data (Fig. 4A). To monitor 
the location of TRAP-γ N-terminus we designed a highly efficient artificial 
(Asn-Ser-Ser) glycosylation site [43] at position 5 (G5N mutant, Fig. 1A). As 
shown in Fig. 4D (lanes 3 and 4), this engineered acceptor site was not 
modified, denoting an N-terminal cytosolic localisation. Finally, by inserting a 
Thr at position 111 (T111) we incorporated an additional glycosylation site 
(Asn-Arg-Thr) in the loop connecting TM2 and TM3 (see Fig. 1A). The 
cytosolic localisation of this region prevented the glycosylation of the 
designed acceptor site (Fig. 4D, lane 5). All in all, our in vivo results clearly 
demonstrated that TRAP-γ subunit contains four TM segments and integrates 
into the eukaryotic membranes with an Nt/Ct cytoplasmic orientation. 
 
4. Discussion 
Membrane proteins participate in a vast array of cellular processes. 
Their correct insertion and orientation within the lipid bilayer is of paramount 
importance for the cell. In eukaryotes, the insertion of most membrane 
proteins occurs through the ER translocon, which performs its activity 
assisted by multiple associated proteins. Among them, the TRAP complex is a 
stoichiometric component of the ribosome-bound translocon complex [44], 
which has been postulated to participate in the early stages of protein 
translocation [9], and in moderating topogenic determinants at a final stage of 
membrane protein biogenesis in vivo [11]. Interestingly, structural data 
showed that membrane-embedded regions of TRAP complex and Sec61 
translocon are in close proximity, which does not block the lateral gate of 
Sec61 translocon that permits TM segment partition into the lipid bilayer [45]. 
Furthermore, proteomic analyses have shown that TRAP can form stable 
complexes with Sec61 and OST even in the absence of bound ribosomes [46]. 
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We have determined the membrane topology of TRAP-γ subunit by 
utilizing glycosylation mapping as marker for lumenal localization and 
evaluating the membrane integration efficiency of its TM segments both in 
microsomal membranes and in eukaryotic cells. Taken together the results 
demonstrate that TRAP-γ subunit consists of four TM segments and its N- 
and C-termini are on the cytosolic side, which is consistent with the in silico 
predictions (Table 1) but reverse to the topology suggested in a seminal work 
[7]. To support our conclusions we assessed the localization of all protein 
domains in vitro but also used gGFP as a topological reporter in S. cerevisiae 
and glycosylation mapping in mammalian cells to allocate both the N- and C-
termini, and the charged segment between the two α-helical hairpins. These 
methodologies offered complementary results that confirmed our 
conclusions. 
TRAP-γ subunit contains two poorly hydrophobic TM segments (TM2 
and TM4), as denoted by the predicted free energy of insertion apparent 
positive values estimated by the ∆G Prediction algorithm (Fig. 1A). Individual 
integration of TM2 in a model protein proved to be very efficient (Fig. 1C). 
However, in these experiments TM4 was not recognised by the translocon as 
a TM sequence (Fig. 1C). In fact, the glycosylation pattern found in this in 
vitro system when TM4 was expressed in-block with preceding TM3 
(including their native turn region) suggests that HR4 is not efficiently 
recognized as an α-helical hairpin component during protein biogenesis (Figs. 
2D and 3B). Surprisingly, in a cellular context, TM4 becomes efficiently 
inserted into the membrane, as found in our in vivo experiments (Fig. 4). 
Nevertheless, the presence of TM1 and/or TM2 might slightly stimulate TM4 
insertion despite their distance in the primary sequence. Whether there is an 
interaction in the tertiary structure between TM4 and TM1 and/or TM2 or 
there is only a temporary cooperation between these hydrophobic regions at 
the time of their insertion [47, 48] cannot be concluded from our results. Either 
scenario the final topology of the protein requires the presence of all TM 
segments and, likely, some additional cellular components. 
The proposed topology of TRAP-γ provides a basis for the functional 
dissection of this stoichiometric translocon component. Functional studies 
involved TRAP in the initial stages of substrate transport in a signal sequence-
modulated manner [9]. Indeed, TRAP luminal domain and stalk observed in 
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structural studies are likely composed of the N-terminal extra-membranous 
regions of the α, β, and δ subunits [45], while the small cytosolic domain that 
binds to the ribosome correspond to the TRAP-γ N-terminus and hairpin-
connecting loop regions [34]. Our results suggest that either signal sequence 
or ribosome interactions with the TRAP complex might occur through γ-
subunit, since TRAP-γ exposes sufficiently large extra-membranous domains 
towards the cytosolic side. This topological information facilitates the design 
of protein-protein interaction screenings and focus future structural studies.  
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Figure legends 
Fig. 1. Insertion of predicted TM segments into microsomal membranes. (a) 
Amino acid sequence of TRAP-γ. Predicted TM regions by the ∆G algorithm 
(http://dgpred.cbr.su.se/)[17, 18] are highlighted in orange boxes and their 
apparent values shown at the bottom. Positive ∆Gapp values, indicative of 
membrane translocation, are shown in red. Negative ∆Gapp values, indicative of 
insertion, are shown in green. Glycosylation acceptor sites are underlined, 
with the mutated or inserted residue shown in bold. A set of oligonucleotides 
(arrowhead dotted lines) was designed to generate TRAP-γ truncated forms, 
which are indicated by the length of the truncated polypeptide (ending 
residue -mer). (B) Schematic representation of the leader peptidase (Lep) 
construct used to report insertion into ER membrane of TRAP-γ HR1, HR2, 
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HR3 and HR4. The HR under study is inserted into the P2 domain of Lep 
flanked by two artificial glycosylation acceptor sites (G1 and G2). Recognition 
of the HR by the translocon machinery as a TM domain (green) locates only 
G1 in the luminal side of the ER membrane preventing G2 glycosylation. The 
Lep chimera will be doubly glycosylated when the HR being tested is 
translocated (red) into the lumen of the microsomes. (C) In vitro translation in 
the presence of membranes of the different Lep constructs. Constructs 
containing the HR1 (residues 30-51, lanes 1-3), HR2 (residues 55-77, lanes 4-6), 
HR3 (residues 138-160, lanes 7-9) and HR4 (residues 163-182, lanes 10-12) 
were translated in the presence (+) and absence (-) of rough microsomes (RM) 
and proteinase K (PK). Bands of non-glycosylated proteins are indicated by a 
white dot; singly and doubly glycosylated proteins are indicated by one and 
two black dots, respectively. In the case of Lep-HR3 construct a triply 
glycosylated band (≈2%) was observed (lane 8) due to the presence of an 
acceptor NNT site (residues 141-143) within the (translocated) hydrophobic 
region. The protected doubly-glycosylated H2/HR4/P2 fragment is indicated 
by an arrowhead. Each gel is representative of three independent 
experiments. 
Fig. 2. Insertion of hydrophobic regions (HRs) using the Lep’ construct. (A) 
Schematic representation of the Lep-derived construct (Lep’). In this Lep’ 
construct tested HRs replaces the H2 domain from Lep. The glycosylation 
acceptor site (G2’) located in the beginning of the P2 domain will be modified 
only if tested HR inserts into the membrane, while the G1’ site, embedded in 
an extended N-terminal sequence of 24 amino acids, is always glycosylated. 
(B) In vitro translation in the presence of membranes (+) and absence (-) of 
rough microsomes (RM) and proteinase K (PK) of HR1 (lanes 1-3) and HR3 
(lanes 4-6). Bands of non-glycosylated proteins are indicated by a white dot; 
singly and doubly glycosylated proteins are indicated by one and two black 
dots, respectively. The protected glycosylated HR/P2 fragment is indicated 
by an arrowhead. (C) In this Lep’ constructs the H2 domain from Lep is 
replaced by TRAP-γ helical hairpins and the N-terminus elongated. (D) In 
vitro translations of Lep’-HR1-2 and Lep’-HR3-4 were performed and labeled 
as in panel (B). Each gel is representative of three independent experiments. 
Fig. 3. In vitro analysis of truncated TRAP-γ constructs. To monitor the 
membrane orientation of truncated TRAP-γ molecules a glycosylatable 
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(NSTMSM) tag (white rectangle) was added at position 54 (54mer), 132 
(132mer), 161 (161mer) and 185 (185mer). (A) Schematic representation of the 
constructs used in the assay. The position of the glycosylation sites is marked 
with a Y symbol. The presence of a TM segment identified by the ∆G 
prediction server (http://dgpred.cbr.su.se/) in each construct and the 
required linker sequence preceding the glycosylatable tag to allow 
glycosylation is also included for 54mer, 161mer and 185mer truncates. (B) In 
vitro translation of the 54mer, 132mer, 161mer and 185mer truncates in the 
presence of rough microsomes (RM). Lanes 1, 3, 5 and 7, samples were treated 
with endoglycosidase H (EndoH) prior to SDS-PAGE analysis. A white dot 
marks the non-glycosylated form of the protein while a black dot indicates 
glycosylation of the C-terminal tag. Glycosylation percentages are shown at 
the bottom. (C) In vitro translations in the presence of RM of 54mer truncated 
constructs were performed bearing an acceptor (NST, NSTMSM) or non-
acceptor (QST, QSTMSM) C-terminal glycosylation tag. Samples were 
subjected to EndoH digestion or mock treated as indicated. White and black 
dots indicate non-glycosylated and glycosylated molecules respectively, as in 
panel (B). (D) Schematic representation of the membrane topology of the 
54mer, 132mer, 161mer and 185mer truncates. A hydrophobic region is noted 
as a green box when inserted in the membrane, or as a red box if it is not 
recognized by the translocon as a TM domain. The position of the 
glycosylatable tag (white rectangle) and its glycosylation status (white and 
black dots, represents non-glycosylated and glycosylated respectively) is also 
shown. Two potential topologies for the 185mer are represented (bottom). 
Experiments were done and quantified at least in triplicates. 
Fig. 4. TRAP-γ membrane topology in eukaryotic cells. (A-C) TRAP-γ 161mer 
and 185mer (full length) were fused to gGFP to analyse the membrane 
topology of the protein in S. cerevisiae. The gGFP is properly folded and thus 
fluorescent in the yeast cytosol, on the other hand once translocated into the 
ER lumen it is glycosylated and the fluorescence is lost. (A) Glycosylation 
status of the 161mer-gGFP and 185mer-gGFP constructs. To confirm the 
glycosylation of the protein samples were treated (+) or mock treated (-) with 
endoglycosidase H (EndoH). White dot indicate non-glycosylated protein 
while black dot point out the glycosylated form. (B) Differential Interference 
Contrast (DIC) and green fluorescent (GFP) images of S.cerevisiae cells 
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expressing the 161mer-gGFP and 185mer-gGFP constructs. (C) Schematic 
representation of the membrane topology adopted by the 161mer-gGFP and 
185mer-gGFP chimeras. The location of TM domains (green), glycosylation 
acceptor sites (white and black dots, according to their glycosylation status) 
and the gGFP (gray line and green structure representation when unfolded 
and properly folded, respectively) is shown. (D) Full-length TRAP-γ subunit 
was expressed in HEK-293T cells to evaluate its membrane topology utilizing 
its glycosylation status as a reporter. To monitor the electrophoretic mobility 
of the non-glycosylated proteins the samples were treated (+) or mock treated 
(-) with EndoH as in panel (a). Wild type (wt) (lanes 1 and 2), Gly5 to Asn 
(G5N) mutant (lanes 3 and 4) and the Thr111 (T111) (lanes 5 and 6) insertion 
were analyzed. Lanes 7 and 8 show the Nipah G protein as an internal 
glycosylation control. White dot indicate non-glycosylated protein while 
black dot point out the molecular weight of a glycosylated G protein. The 
number of modified glycosylation sites is shown between brackets. 
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Table 1. Computer analysis of TRAP-γ amino acid sequence. 
Algorithm Nº TMs (starting-ending position) Topology 
SOSUI 3(26-48)(56-78)(138-157) NAa 
Split 3(29-49)(55-78)(135-158) Ntcyt/Ctlum 
OCTOPUS 3(29-50)(57-78)(135-157) Ntcyt/Ctlum 
PHD 3(31-51)(54-77)(140-164) Ntcyt/Ctlum 
TOP PRED 2 4(28-48)(55-77)(140-160)(164-184) Ntcyt/Ctcyt 
TMHMM 4(29-51)(55-77)(138-157)(162-184) Ntcyt/Ctcyt 
TM pred 4(30-47)(50-77)(138-160)(165-181) Ntcyt/Ctcyt 
MEMSAT 4(30-48)(55-77)(135-155)(162-179) Ntcyt/Ctcyt 
HMMTOP 4(30-48)(59-77)(135-157)(166-184) Ntcyt/Ctcyt 
TOPCONS 4(30-50)(55-75)(136-156)(163-183) Ntcyt/Ctcyt 
ΔG PRED 4(30-51)(55-77)(138-160)(163-182) NAa 
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